Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Lexeo Therapeutics Partners with Perceptive Xontogeny Venture Funds and venBio Partners to Advance RNA Therapeutics for Cardiac Diseases with $40 Million Investment.

Jun 24, 2025•12 months ago

Contract Type

partnership

New YorkBiotechnologyHealth CareGeneticsTherapeutics

Description

Lexeo Therapeutics has announced a strategic partnership to develop therapies for genetic cardiac diseases, supported by an investment of up to $40 million. This funding will help seed a new entity focused on novel non-viral RNA delivery platforms. The partnership aims to revolutionize the treatment of cardiovascular diseases.

Company Information

Company

Lexeo Therapeutics

Location

New York, New York, United States

About

Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Lexeo Therapeutics 's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.